Status:
COMPLETED
Trypan Blue Versus Brillant Blue for Epiretinal Membranes
Lead Sponsor:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Conditions:
Idiopathic Epiretinal Membranes
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Membraneppeling alone versus Membranepeeling with Membrane Limitans Interna Pelling using two different Dyes for Epiretinal Membrane Surgery.
Eligibility Criteria
Inclusion
- Idiopathic eperetinal membranes
- Phakic or pseudophakic eyes
- Age over 60 years
Exclusion
- Secondary epiretinal membranes
- Severe ocular pathologies
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00757380
Start Date
July 1 2008
End Date
August 1 2015
Last Update
January 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Vienna, Vienna, Austria, 1030